Grundium has incorporated Olympus’ high-performance X Line objectives into its Ocus portable single slide scanners to enable convenient creation and sharing of high-quality digital slides.
ELITechGroup, a provider of global vapor pressure osmometer technology, has acquired GONOTEC, a...
The Tech Guide from the June 2021 issue of Clinical Lab Products includes immunoassay analyzers from Beckman Coulter, Diazyme, Fujirebio, Grifols, Ortho Clinical Diagnostics, Randox, Siemens Healthineers, and more.
The Zeiss Xradia CrystalCT micro-computed tomography (microCT) system enables 3D crystallographic imaging of polycrystalline materials for a wide range of samples.
Epredia has been appointed as a global distribution partner for Aiforia's portfolio of preclinical and clinical pathology tools, including segment exclusivity for distribution in the United States.
With eight new configurations, cobas pro integrated solutions offers labs greater flexibility to ramp up their testing capacity to adapt to evolving testing needs.
The completely overhauled BD online purchasing experience offers intuitive navigation and a fully integrated shopping experience to address flow cytometry users' buying needs.
Gravity began offering blood testing with COVID-19 antibody tests and now also offers a new menu of blood tests to monitor and screen for a variety of conditions.
Accelerate Diagnostics, Inc. has launched a new IVD configuration of its Accelerate PhenoTest BC kit in the United States.
The Thermo Scientific FAIMS Pro Duo interface simplifies workflows and extends orthogonal selectivity for greater mass spectral performance.
This additional funding will allow Selux to continue implementing its microbiology roadmap and commercialize its Next Generation 'Phenotyping' (NGP) platform for rapid antimicrobial susceptibility testing.
Seegene announced that it has signed a partnership with Bio-Rad for the development of infectious disease molecular diagnostic products.
Technology developed by UCL and AHRI researchers could transform the ability to accurately interpret HIV test results.
The urine test, which is expected to be available by mid-2022, will use highly sensitive liquid biopsy technology developed by Nonacus and a panel of biomarkers validated by Birmingham University researchers to diagnose bladder cancer.